IP Verse

Institut National De La Santé Et De La Recherche Médicale (inserm) patent opposition analysis

Latest patents of Institut National De La Santé Et De La Recherche Médicale (inserm) opposed by its competitors

The following table provides an overview of the latest patents of Institut National De La Santé Et De La Recherche Médicale (inserm) that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3911354Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin Gene4
EP3920970Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse Events1
EP3444271Oct 6, 2021Il-15 And Il-15Raplha Sushi Domain Based Modulokines2
EP3256573Dec 9, 2020Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography1
EP2900820Nov 18, 2020Methods For Producing A Population Of Pancreatic Beta-Cells1
EP2909232Mar 11, 2020Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)1
EP3030575Jul 11, 2018Il-15 And Il-15Raplha Sushi Domain Based Modulokines1

Top competitors of Institut National De La Santé Et De La Recherche Médicale (inserm)